|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
|
|---|---|---|---|---|
| Revenues | ||||
| Cost of revenues | ||||
| Gross Profit | ||||
| Research and development expenses | ||||
| Selling, general and administrative expenses | ||||
| Depreciation and amortization in respect of technology and capitalized development costs | ||||
| Other income (expenses) | ||||
| Share of losses of equity method investees | ||||
| Operating Income (Loss) | ||||
| Finance expenses, net | ||||
| Financial Income | ||||
| Financial Expense | ||||
| Total finance expenses, net | ||||
| Profit (loss) before taxes on income | ||||
| Tax benefits (expenses) | ||||
| Profit (loss) for the period | ||||
| To non-controlling interests | ||||
| Earnings (loss) per share attributed to shareholders of the Company: | ||||
| Basic earnings (loss) per share | ||||
| Diluted earnings (loss) per share |
Loading...
